HISTOLAB PRODUCTS ApS: Financial statements 2021
CVR: 28292090
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
HISTOLAB PRODUCTS ApS (CVR 28292090) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 13,442,231 and a net result of DKK 68,320 compared with DKK 545,751 the year before. That is an increase of 9.6% compared with the year before. The profit margin was 0.5%. Equity in the 2021 report amounted to DKK 2,839,403. The solvency ratio was 52.6%. The company had 1 employee in the financial year.
- Revenue
- DKK 13,442,231
- Gross Profit
- DKK 1,201,577
- Profit/Loss
- DKK 68,320
- Equity
- DKK 2,839,403
- Total Assets
- DKK 5,403,066
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 13.4 mio. | 1.2 mio. | 68 t. | 2.8 mio. | 1 |
| 2020 | 12.3 mio. | 1.8 mio. | 546 t. | 2.8 mio. | 1 |
| 2019 | 8.5 mio. | 1.3 mio. | 269 t. | 2.2 mio. | 1 |
| 2018 | 8.2 mio. | 1.5 mio. | 375 t. | 2 mio. | 1 |
| 2017 | 7.4 mio. | 1.5 mio. | 415 t. | 1.6 mio. | 1 |
Official annual report
Find more companies like HISTOLAB PRODUCTS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
HISTOLAB PRODUCTS ApS has published its annual report for 2020. Revenue came to DKK 12,265,249, and the net result was DKK 545,751.
About HISTOLAB PRODUCTS ApS
HISTOLAB PRODUCTS ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2004. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named ALGOL PHARMA ApS. The management consists of Caj Patrik Joakim Eurenius. The board consists of Caj Patrik Joakim Eurenius (chair) and Frida Birgitta Ekstrand. The company is owned by Histolab Products AB. The company has 1 employee (2026). In 2025, the company reported revenue of DKK 14,888,720 and a net result of DKK 107,970 compared with DKK 59,499 the year before. Equity in the 2025 report amounted to DKK 3,130,036.